Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer
November 03, 2015 11:50 ET
|
Neurogastrx
CAMPBELL, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Neurogastrx, a biopharmaceutical company engaged in developing novel drugs for gastrointestinal disorders, today announced the appointment of...
Tranzyme Pharma Announces Top-Line Results of TZP-102 Phase 2b Trial
November 15, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
Preliminary Analysis Indicates Trial Did Not Meet Primary Endpoint
Tranzyme to Host Conference Call Today at 8:00 am ET
RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2012 (GLOBE NEWSWIRE) -- ...
Tranzyme Pharma Announces Third Quarter 2012 Financial Results
November 08, 2012 16:30 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class...
Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012
October 25, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss...
Tranzyme Pharma to Present at BIO Investor Forum on October 10, 2012
October 03, 2012 13:30 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 3, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, will present at the 11th Annual BIO Investor...
Tranzyme Pharma Raises $10 Million in Registered Direct Offering
September 13, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it has agreed to sell approximately 2.6 million shares of its common stock at a...
Tranzyme Pharma to Report Fourth Quarter and Year-End 2011 Financial Results
February 14, 2012 05:10 ET
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Wednesday, February 29, 2012 at 8:30 am ET to...